To explain this phenomenon, two theories have been posed: either, the amplification of HER2 is already acquired during tumor progression and dissemination of tumor cells [52], or HER2-positive cells of the primary tumor have a greater tendency to split from the tumor and form metastases [49,51]. This evidence concerns the gene ERBB2 and neoplasm.